Literature DB >> 21946310

Unilateral nigrostriatal 6-hydroxydopamine lesions in mice II: predicting l-DOPA-induced dyskinesia.

Gaynor A Smith1, Andreas Heuer, Stephen B Dunnett, Emma L Lane.   

Abstract

In the 6-hydroxydopamine (6-OHDA) lesioned rodent the location of the lesion produces significantly different behavioural phenotypes, responses to the dopamine precursor l-3,4-dihydroxyphenylalanine (l-DOPA) and neuropathology. Lesion extent is commonly determined by a series of motor tests, but whether any of these tests have a relationship to the development and predictability of dyskinesia is unknown. We used mice with 6-OHDA lesions of the striatum, medial forebrain bundle and substantia nigra to examine the relationship between a range of tests used to determine motor function in the absence of l-DOPA: rotarod, cylinder, corridor, the balance beam, locomotor activity, psycho-stimulant and spontaneous rotational behaviour. The mice were subsequently treated with l-DOPA in progressively increasing doses and the development of l-DOPA-induced dyskinesia assessed. Most of these tests predict dopamine depletion but only rotarod, spontaneous rotations, apomorphine-induced rotations and locomotor activities were significantly correlated with the development of dyskinesia at 6mg/kg and 25mg/kg l-DOPA. The losses of dopaminergic neurons and serotonergic density in the ventral and dorsal striatum were dependent upon lesion type and were also correlated with l-DOPA-induced dyskinesia. The expression of FosB/ΔFosB was differentially affected in the striatum and nucleus accumbens regions in dyskinetic mice according to lesion type.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21946310     DOI: 10.1016/j.bbr.2011.09.025

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  10 in total

1.  D-512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti-Parkinsonian efficacy than ropinirole in Parkinsonian rats.

Authors:  David Lindenbach; Banibrata Das; Melissa M Conti; Samantha M Meadows; Aloke K Dutta; Christopher Bishop
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

2.  Enhancement of polysialic acid expression improves function of embryonic stem-derived dopamine neuron grafts in Parkinsonian mice.

Authors:  Daniela Battista; Yosif Ganat; Abderrahman El Maarouf; Lorenz Studer; Urs Rutishauser
Journal:  Stem Cells Transl Med       Date:  2013-12-05       Impact factor: 6.940

3.  L-DOPA Reverses the Increased Free Amino Acids Tissue Levels Induced by Dopamine Depletion and Rises GABA and Tyrosine in the Striatum.

Authors:  Oscar Solís; Patricia García-Sanz; Antonio S Herranz; María-José Asensio; Rosario Moratalla
Journal:  Neurotox Res       Date:  2016-03-10       Impact factor: 3.911

4.  Modulation by Estradiol of L-Dopa-Induced Dyskinesia in a Rat Model of Post-Menopausal Hemiparkinsonism.

Authors:  Kaja Kolmančič; Marko Živin; Maja Zorović
Journal:  Life (Basel)       Date:  2022-04-26

5.  The effects of BMY-14802 against L-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian rat.

Authors:  Nirmal Bhide; David Lindenbach; Margaret A Surrena; Adam A Goldenberg; Christopher Bishop; S Paul Berger; Melanie A Paquette
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

6.  Cell intrinsic and extrinsic factors contribute to enhance neural circuit reconstruction following transplantation in Parkinsonian mice.

Authors:  Jessica Kauhausen; Lachlan H Thompson; Clare L Parish
Journal:  J Physiol       Date:  2012-10-08       Impact factor: 5.182

7.  Axial levodopa-induced dyskinesias and neuronal activity in the dorsal striatum.

Authors:  Stephanie L Alberico; Young-Cho Kim; Tomas Lence; Nandakumar S Narayanan
Journal:  Neuroscience       Date:  2016-12-09       Impact factor: 3.590

8.  Dopaminergic Progenitors Derived From Epiblast Stem Cells Function Similarly to Primary VM-Derived Progenitors When Transplanted Into a Parkinson's Disease Model.

Authors:  Sophie V Precious; Gaynor A Smith; Andreas Heuer; Ines Jaeger; Emma L Lane; Stephen B Dunnett; Meng Li; Claire M Kelly; Anne E Rosser
Journal:  Front Neurosci       Date:  2020-04-07       Impact factor: 4.677

9.  Effect of kaempferol on the transgenic Drosophila model of Parkinson's disease.

Authors:  Falaq Naz; Smita Jyoti; Yasir Hasan Siddique
Journal:  Sci Rep       Date:  2020-08-14       Impact factor: 4.379

10.  An assessment of the rescue action of resveratrol in parkin loss of function-induced oxidative stress in Drosophila melanogaster.

Authors:  Adeola O Adedara; Ayoade D Babalola; Flora Stephano; Ifeoluwa O Awogbindin; James O Olopade; João B T Rocha; Alexander J Whitworth; Amos O Abolaji
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.